Biopharma Insights

Proscia Enhances Preclinical R&D Platform: Streamlining Pathology Workflows for Faster Drug Safety Decisions

Proscia, a company specializing in digital and computational pathology solutions, recently announced updates to its preclinical research and development (R&D) …

Continue ›››

AI and Cryo-EM: A Powerful Alliance for Unraveling Biological Mysteries

As we delve deeper into the uncharted territories of biotechnology, the convergence of artificial intelligence (AI) and cryo-electron microscopy (Cryo-EM) …

Continue ›››

Beyond Traditional Medicine: Exploring the Revolutionary Therapies Transforming Patient Care

Biotechnology has revolutionized the healthcare industry, and with the increasing demand for advanced therapies, the focus has shifted towards innovative …

Continue ›››

Decentralized Clinical Trials Software’s in 2023: What to Expect

Healthcare technology is advancing at an unprecedented pace, and the clinical trials industry is no exception. The past few years …

Continue ›››

The Time for Breakthroughs in Antibiotic Discovery

Since a revolutionary discovery of penicillin in 1928 by Scottish bacteriologist and Nobel laureate Alexander Fleming, numerous inventions of new …

Continue ›››

Unlocking the Proteome's Secrets: The Advancement of Single-Molecule Protein Sequencing Techniques

Even though characterizing the proteome, the complete set of proteins made by a cell or organism, can yield important insights …

Continue ›››

2022 in Retrospect: 10 Breakthrough Technologies in Drug Discovery

Reflecting on 2022, let’s review several breakthrough technologies that are shaping the future of biology research and drug discovery. I …

Continue ›››

15 Biopharma Research Trends to Watch in 2022

Table of contents:    mRNA vaccines and RNA therapies  Epitranscriptomics Targeting RNA with small molecules Deep learning and big data …

Continue ›››

14 Publicly Traded Companies Developing Longevity Therapeutics

The longevity industry has been growing throughout the past decades, attracting more attention to the healthy aging process and searching …

Continue ›››

Choosing Cancer Weapons With the Best Aim

In oncology, we do the best we can. We give drugs with 10-20% chances of working because we have nothing …

Continue ›››

MGI Tech Expands Sequencing Capabilities in Europe

In November, MGI Tech Co, a Shenzhen-based biotechnology company, an affiliated company of BGI Group, committed to building core tools and …

Continue ›››

7 Companies Using AI to Design Protein Degraders

Our cells function in the continuous mode of producing and degrading proteins, keeping the balance between these two processes to …

Continue ›››